Guangxi Medical University
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
-
Can a targeted chemo procedure stop liver cancer from coming back after surgery?
Disease control Recruiting nowThis study is for people with liver cancer who have had surgery to remove their tumor but are at high risk of the cancer returning. Researchers want to see if adding a procedure called TACE (which delivers chemotherapy directly to the liver) after surgery can help keep the cancer…
Phase: PHASE3 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 17, 2026 06:05 UTC
-
New surgery may offer better relief for stomach cancer patients with blockage
Symptom relief Recruiting nowThis study compares a new type of stomach bypass surgery (partial stomach-partitioning gastrojejunostomy) to the standard surgery for people with advanced stomach cancer that blocks food from leaving the stomach. The goal is to see which surgery better helps patients eat again, w…
Phase: NA • Sponsor: Guangxi Medical University • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC
-
2000 liver cancer patients studied to find optimal pre-surgery therapy
Knowledge-focused Recruiting nowThis study looks back at the medical records of 2000 people with liver cancer in Guangxi, China, who received treatment before surgery (called conversion or neoadjuvant therapy). The goal is to find out which treatments work best and which patients benefit the most. Researchers w…
Sponsor: Guangxi Medical University • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC